Larvol Delta - A-Study-to-Continue-the-Administration-of-Deucravacitinib-in-Participants-With-Systemic-Lupus-Erythematosus-SLE-or-Discoid-andor-Subacute-Cutaneous-Lupus-Erythematosus-DLESCLE-Who-Have-Completed-Study-IM011074-or-Study-IM011132

Reblozyl (luspatercept-aamt) - BMS, Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT05664737

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next